Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 22, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that it intends to offer, subject to market conditions and other factors, $500.0...
View HTML
Toggle Summary Omnicell to Present at Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 1, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences: 2020 Wells Fargo Virtual Healthcare...
View HTML
Toggle Summary Peninsula Regional Medical Center Extends Partnership With Omnicell to Enhance Safety and Efficiency in Sterile Compounding
Combination of technology, services, and data supports more cost-effective workflows MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Aug. 17, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced...
View HTML
Toggle Summary Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Expands pharmacy supply chain capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy , building on the recent launch of Omnicell One Expected to be immediately accretive to non-GAAP...
View HTML
Toggle Summary Omnicell Reports Second Quarter 2020 Results
GAAP revenues of $199.6 million and net loss per diluted share of $0.10 Non-GAAP revenues $199.6 million and net income per diluted share of $0.37 Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 28, 2020-- Omnicell, Inc....
View HTML
Toggle Summary Omnicell to Release Second Quarter 2020 Earnings Results on July 28, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 21, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, July 28, 2020 , to discuss the Company’s Second Quarter...
View HTML
Toggle Summary Omnicell Streamlines Pharmacy Supply Chain Through Cloud-Based Predictive Intelligence Solution
Omnicell One is a technology-enabled service leveraging cloud-based data and predictive, prescriptive analytics to improve clinical, financial and operational outcomes MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 20, 2020-- Omnicell, Inc. , (NASDAQ:OMCL), a leading provider of medication...
View HTML
Toggle Summary Omnicell Reports First Quarter 2020 Results
GAAP and non-GAAP revenues of $229.7 million , up 13.4% year-over-year GAAP net income per diluted share of $0.26 , up 225.0% year-over-year Non-GAAP net income per diluted share of $0.66 , up 8.2% year-over-year Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Hold Virtual 2020 Annual Meeting of Stockholders
Event Webcast Scheduled for Tuesday, May 26 MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--May 1, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that due to the public health impact of...
View HTML
Toggle Summary Omnicell to Release First Quarter 2020 Earnings Results on May 7, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Apr. 28, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, May 7, 2020 , to discuss the Company’s First Quarter 2020...
View HTML